Company Filing History:
Years Active: 2021
Title: Innovations of Haiyuan Yang in Gene Editing
Introduction
Haiyuan Yang is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of gene editing, particularly through his work with CRISPR technology. His innovative approaches have the potential to revolutionize genetic research and applications.
Latest Patents
Haiyuan Yang holds a patent for a CRISPR/Cas9 vector combination and its application in gene knockout. This patent includes a specific SgRNA combination targeting the GGTA1, CMAH, and β4GalNT2 genes. The CRISPR/Cas9 vector combination comprises vectors specifically designed for each of these genes. The application of this technology allows for the effective knockout of these genes, achieving knockout rates of 56%, 63%, and 41%, respectively. This advancement could lead to the development of genetically modified pigs with immune rejection-related genes knocked out, facilitating the acquisition of heart valves from these animals.
Career Highlights
Yang's career is marked by his dedication to advancing genetic engineering techniques. His work has garnered attention in the scientific community, showcasing the practical applications of CRISPR technology in medicine and biotechnology.
Collaborations
He collaborates with notable colleagues, including Yifan Dai and Ying Wang, who contribute to his research endeavors. Their combined expertise enhances the impact of their work in the field of gene editing.
Conclusion
Haiyuan Yang's innovative contributions to gene editing through his CRISPR/Cas9 patent highlight the potential for significant advancements in genetic research. His work not only showcases his expertise but also paves the way for future developments in biotechnology.